Author

V. Arora

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Organism:rat· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Chakraborty· 3 shared A. Diwan· 3 shared P. Holkar· 3 shared V. Chiniga· 3 shared Y. Thakur· 3 shared B. Pond· 2 shared J. Tatake· 2 shared N. Holkar· 2 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

A. Chakraborty

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Kinase inhibitor-induced cell-type specific vacuole formation in the absence of canonical ATG5-dependent autophagy

S. Jose, H. Sharma, J. Insan, K. Sharma, V. Arora, S. Dhamija, N. Eid, M. B. Menon

This study shows that SB202190 induces cell-type specific vacuole formation independent of canonical autophagy, involving RAB7 and revealing potential therapeutic strategies.

bioRxiv · Aug 27, 2023Cell Biology

Dual Effects of NV-CoV-2 Biomimetic Polymer: An Antiviral regimen against COVID-19

A. Chakraborty, A. Diwan, V. Chiniga, V. Arora, P. Holkar, Y. Thakur, J. Tatake, R. Barton, N. Holkar, B. Pond

This paper evaluates NV-CoV-2 polymer and its encapsulation of remdesivir (NV-CoV-2-R) for antiviral efficacy against COVID-19, showing improved stability and effectiveness compared to remdesivir alone.

bioRxiv · Nov 24, 2021 · PreprintPharmacology & Toxicology

Nanoviricides platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo

A. Chakraborty, A. Diwan, V. Arora, Y. Thakur, V. Chiniga, J. Tatake, P. Holkar, N. Holkar, B. Pond

This paper reports on a non-clinical study of NV-CoV-2 polymer and its encapsulation of Remdesivir, showing improved in vivo stability and safety in rats.

bioRxiv · Nov 17, 2021 · PreprintPharmacology & Toxicology

Nanoviricides Platform Technology based NV-387 polymer Protects Remdesivir from Plasma-Mediated Catabolism in vitro:Importance of its increased lifetime for in vivo action

A. Chakraborty, A. Diwan, V. Arora, Y. Thakur, P. Holkar, V. Chiniga

The paper demonstrates that encapsulating remdesivir with the NV-387 polymer enhances its stability in plasma in vitro, potentially improving its in vivo efficacy.

bioRxiv · Oct 22, 2021 · PreprintCell Biology